Physician profile
Cynthia E Allen
NPI 1679668487
$9,736.20
in general payments reported to CMS, 2019-2025
46 companies · $28.18 in 2025
The $28.18 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,981 · 2020: $1,422 · 2021: $1,921 · 2022: $1,835 · 2023: $1,557 · 2024: $992 · 2025: $28.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,527 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,526.50 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,687.56 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Pfizer INC. | $984.20 | 2019-2024 | |
| Novo Nordisk INC | $974.95 | 2019-2024 | Rybelsus, Ozempic, Saxenda |
| Merck Sharp & Dohme LLC | $659.67 | 2019-2023 | Verquvo, Belsomra, Lagevrio |
| Astellas Pharma US INC | $620.56 | 2019-2024 | Veozah, Myrbetriq |
| Amgen INC. | $456.96 | 2019-2023 | Evenity, Prolia |
| Lilly USA, LLC | $422.08 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Allergan, INC. | $400.47 | 2019-2020 | |
| Glaxosmithkline, LLC. | $330.58 | 2020-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $298.85 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.69 | 2019-2024 | Synjardy, Jardiance |
| Janssen Pharmaceuticals, INC | $258.76 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $232.90 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $217.46 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $204.61 | 2021-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.